Company profile: Artes Biotechnology
1.1 - Company Overview
Company description
- Provider of biopharmaceutical production processes and CDMO services, including microbial cell line and process development, manufacturing of test and preclinical material, and vaccine development. Offers pre-developed recombinant protein processes (biosimilars, vaccines, enzymes), technology transfer and proprietary cell line licensing; supplies recombinant reagents from yeast and bacterial platforms; and develops yeast (Hansenula polymorpha) and E. coli systems.
Products and services
- License Offer: ARTES offers pre-developed recombinant protein processes for biosimilars, vaccines, and enzymes, with technology transfer and licensing of proprietary microbial cell lines for deployment
- CDMO Services: ARTES architects contract development and manufacturing, including microbial cell line and process development, vaccine development, and production of test and preclinical materials at preclinical-scale
- Microbial Cell Line Development: ARTES engineers microbial cell lines for recombinant protein production, offering expression, secretion, and genomic characterization capabilities for efficient development of target proteins
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Artes Biotechnology
AnaBios
HQ: United States
Website
- Description: Provider of human-focused contract research services and products for biotech and pharma drug discovery, using ex vivo studies of human donor organs and tissues. Includes ethical human tissue and cell procurement, human primary cells and media, RIN analysis, custom tissue collection, cryopreserved human hepatocytes, and high-quality human heart tissue for cardiovascular preclinical research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AnaBios company profile →
Quotient Sciences
HQ: United Kingdom
Website
- Description: Provider of formulation development, clinical pharmacology, and clinical-to-commercial manufacturing. Services span preformulation; small-batch supply to accelerate POC; 14-day make-test cycles in humans; process development and scale-up through Phase II/III; commercial manufacturing for ANDA/NDA/MAA/Japanese NDA; and Translational Pharmaceutics integrating formulation, adaptive GMP manufacturing, and clinical research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Quotient Sciences company profile →
Appletree CI
HQ: Switzerland
Website
- Description: Provider of specialized CRO and CSO services in ophthalmology and medical device investigations, offering global regulatory affairs and end-to-end clinical development solutions, flexible functional service outsourcing, real-world evidence and virtual studies, advisory and talent support, and strategic resourcing across 11 European nations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Appletree CI company profile →
PharmaCell
HQ: The Netherlands
Website
- Description: Provider of GMP-certified cell-culturing and contract manufacturing services for cellular therapies and regenerative medicine in Europe, operating facilities in Maastricht and Geleen. Serves world-leading commercial cell therapy companies and offers support or partnership to R&D companies through an extensive network.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PharmaCell company profile →
NeuroRx
HQ: Canada
Website
- Description: Provider of clinical trial services for new drugs in multiple sclerosis and other neurological diseases, including advanced MRI analysis; acquisition and analysis of non-conventional MRI (magnetization transfer imaging, magnetic resonance spectroscopy); MRI protocol guidance and manuals; compliant quantification forms; trial-specific scan tracking with validated database; site setup and supervision.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NeuroRx company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Artes Biotechnology
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Artes Biotechnology
2.2 - Growth funds investing in similar companies to Artes Biotechnology
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Artes Biotechnology
4.2 - Public trading comparable groups for Artes Biotechnology
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →